The lower mRNA expression of SIGLEC10 in CLL cells may directly cause the lower surface expression, however posttranslational mechanism such as downmodulation of Siglec‐10 protein from the surface of CLL cells cannot be excluded. The gene discussed is SIGLEC10; the disease is B-cell chronic lymphocytic leukemia.